Baseline anti-NS4a antibodies in combination with on-treatment quantitative HCV-RNA reliably identifies nonresponders to pegylated interferon-ribavirin combination therapy after 4 weeks of treatment.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples